Conference Coverage

Guest: Carel le Roux, MBChB, MSC, FRCP, FRCPath, PhD New findings from the SYNCHRONIZE-1 trial reveal that survodutide's impact extends beyond weight reduction, with a demonstrated decrease in liver fat and meaningful improvements across multiple markers of metabolic health in patients without type 2 diabetes. Dr. Carel le Roux joins us to share the efficacy and safety data and explore what these...

Guest: John W. Ostrominski, MD, MPH Despite advances in glycemic management, blood pressure control, lipid lowering, and disease-modifying therapies, patients with chronic kidney disease (CKD) and type 2 diabetes continue to face substantial residual cardiovascular risk. In this program, Dr. John Ostrominski reviews emerging evidence linking low-grade systemic inflammation to adverse cardiovascula...

Guest: Kimberly Narain, MD, MPH, PhD Cost-related medication nonadherence remains a significant but often hidden barrier to effective diabetes care, with out-of-pocket costs preventing patients from accessing essential therapies. Dr. Kimberly Narain joins us to explain why clinicians should look beyond insurance status alone and consider affordability challenges when developing strategies to impro...

Host: Steve Jackson, PharmD Guest: Souptik Barua, PhD Guest: Emily Johnston, MPH, PhD Can older adults successfully engage with telehealth, wearable technology, and digital health tools to prevent type 2 diabetes? In this conversation with Dr. Steve Jackson, Dr. Emily Johnston and Dr. Souptik Barua discuss emerging insights on how these strategies could improve accessibility and engagement in a hi...

Guest: Jaime Imitola, MD As stem cell therapies continue to generate significant interest among patients with multiple sclerosis (MS), clinicians must be prepared to distinguish between approved treatments, investigational approaches, and unproven interventions marketed through stem cell tourism. Hear more as Dr. Jaime Imitola discusses the current landscape of stem cell therapies in MS, the risks...

Guest: Javier Morales, MD, FACP, FACE From proactive screening to once-weekly insulin, the treatment landscape for type 1 diabetes is evolving rapidly. Join Dr. Javier Morales to hear about current and emerging care strategies in these patients, a topic he also discussed at the 2026 American Diabetes Association Scientific Sessions. Dr. Morales is an Associate Clinical Professor of Medicine at the...

Guest: Javier Morales, MD, FACP, FACE For patients with obesity and type 2 diabetes (T2D), emerging incretin-based therapies that target multiple metabolic pathways are producing meaningful weight-loss outcomes. To learn more about these care strategies, tune in as Dr. Javier Morales shares key updates from the 2026 American Diabetes Association Scientific Sessions. Dr. Morales is an Associate Cli...

Guest: Emily MacDuffie, MD A recent survey conducted by physicians at Penn Medicine found that one-third of female oncologists reported experiencing infertility. Join Dr. Emily Macduffie, Radiation Oncology Resident Physician at Penn Medicine, as she speaks about potential solutions related to infertility for women in medicine based on her 2023 ASCO presentation.

Guest: Alison Wakoff Loren, MD, MSCE Cancer occurs in approximately 1 in every 1,000 pregnant patients and requires complex solutions from a multidisciplinary team. Learn more about the expanding management options for these patients with Dr. Alison Loren, Chief of the Division of Hematology and Oncology at the University of Pennsylvania Perelman School of Medicine.

Guest: Elizabeth S. Gromisch, PhD Cognitive changes are a common but complex aspect of multiple sclerosis care, making practical and accessible screening strategies essential. In this program, Dr. Elizabeth Gromisch explores both traditional and digital cognitive screening tools for MS and shares real-world insights on selecting and implementing assessments across a range of clinical settings. Dr....

Guest: Avery H. LaChance, MD, MPH, FAAD Cutaneous dermatomyositis has a distinct pattern of skin findings that, once recognized, can make diagnosis much more straightforward. Tune in to hear Dr. Avery H. LaChance walk through the key visual clues and exam tips that help bring this condition into focus. Dr. LaChance is Director of the Connective Tissue Disease Clinic, Director of the Advanced Psori...

Guest: Jeanette Andrade, PhD, RDN, LDN, FAND Food and nutrition insecurity are increasingly recognized as critical factors affecting outcomes for patients with chronic kidney disease (CKD). That’s why Dr. Jeanette Andrade joins us to share practical screening strategies and emerging solutions, like dialysis center food pantries and digital health tools. Dr. Andrade is an Associate Professor and th...

Guest: Abdallah Geara, MD Early diagnosis is critical in IgA nephropathy, as most patients present with established kidney damage by the time they are identified. Tune in to hear Dr. Abdallah Geara highlight the importance of timely recognition and how emerging therapies are transforming treatment and improving patient outcomes when implemented early.

Guest: Deborah Clegg, PhD Not all potassium is created equal, especially in the context of chronic kidney disease (CKD). That’s why Dr. Deborah Clegg joins us to explore the key differences between potassium from whole foods and additives, emphasizing how bioavailability impacts serum potassium levels and hyperkalemia risk. She also examines how kidney function, comorbidities, medications, and met...

Guest: Deborah Clegg, PhD For decades, potassium restriction has been a cornerstone of dietary management in patients with chronic kidney disease (CKD), but is it always necessary? Here to answer that exact question is Dr. Deborah Clegg. Since many patients may already be consuming potassium at restricted levels, she emphasizes the importance of individualized dietary assessment before imposing fu...

Guest: Abdallah Geara, MD IgA nephropathy is often asymptomatic and frequently identified through incidental lab findings, making timely recognition challenging. Hear Dr. Abdallah Geara discuss key diagnostic strategies that may help optimize long-term care for this disease. Dr. Geara is an Associate Professor of Clinical Medicine and the Clinical Director of the Glomerular Disease Program at the...

Guest: Jeanette Andrade, PhD, RDN, LDN, FAND Food and nutrition insecurity in chronic kidney disease (CKD) can be difficult to detect, even when patients appear clinically stable. To help highlight this challenge, Dr. Jeanette Andrade presents a case from her research illustrating how social and financial stressors affected a dialysis patient’s dietary intake and food access. Dr. Andrade is an Ass...

Presenter: Louis Bessette MD, FRCP(C), MSc From early arthritis treatment pathways to emerging digital health tools, the 2026 Congress of Clinical Rheumatology East conference spotlights the clinical and scientific advances shaping the future of rheumatology care. Joining us to outline those key themes and sessions is Dr. Louis Bessette, Professor of Medicine at Université Laval and the Director o...

Guest: Avery H. LaChance, MD, MPH, FAAD Acute and subacute cutaneous lupus each have recognizable skin presentations that can help guide diagnosis, especially when distinguishing them from similar conditions. Join Dr. Avery H. LaChance as she breaks down their key diagnostic features, common mimics, and important considerations for clinical evaluation. Dr. LaChance is Director of the Connective Ti...

Presenter: Louis Bessette MD, FRCP(C), MSc What can nearly two decades of real-world data teach us about optimizing care in early inflammatory arthritis? Find out with Dr. Louis Bessette as he reviews key findings from the Canadian Early Arthritis Cohort (CATCH), a national, multicenter study of nearly 4,000 patients enrolled within weeks of symptom onset. Not only is Dr. Bessette a Professor of M...

Host: Matt Birnholz, MD Guest: Karen Roy, MSc For medical affairs teams, demonstrating the value and impact of educational initiatives in a meaningful and measurable way is essential. At the 2026 Medical Affairs Professional Society (MAPS) Annual Meeting, Dr. Matt Birnholz spoke with Ms. Karen Roy, CEO and Co-Founder of Infograph-ed, about how CME-informed strategies can elevate planning, content...

Host: Matt Birnholz, MD Guest: Brandon Young, PhD Today’s medical science liaisons (MSLs) are navigating a rapidly shifting healthcare landscape. Step inside the evolving world of medical affairs as Dr. Matt Birnholz sits down with Dr. Brandon Young, senior MSL at CSL Seqirus, to uncover how communication, collaboration, and emerging technologies are shaping the future of the field. Gain insights...

Host: Matt Birnholz, MD Guest: Tony Page Early, integrated insights can dramatically improve pharmaceutical launch outcomes and reduce the risk of missed expectations. Discover best practices for aligning market needs with clinical strategy and leveraging AI for smarter insight planning with Dr. Matt Birnholz and Mr. Tony Page, who shared their perspectives at the 2026 Medical Affairs Professional...

Host: Matt Birnholz, MD Guest: Renu Juneja, PhD What do pharmaceutical leaders actually need from their agency partners? Find out as Dr. Matt Birnholz sits down with Dr. Renu Juneja to explore how insight-led collaboration can unlock stronger relationships, faster timelines, and more impactful medical education. In this conversation at the 2026 Medical Affairs Professional Society (MAPS) Annual Me...

Host: Matt Birnholz, MD Guest: Michael DeLuca, PharmD, MBA, MSRA From launch excellence to global operational support, medical affairs teams are evolving to enhance scientific exchange and drive meaningful outcomes for patients. Learn more with Dr. Matt Birnholz and Dr. Michael DeLuca, Executive Vice President of Global Medical Affairs and Medical Information at EVERSANA, who explored key trends s...